Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group.

L-Asparaginase, in the dose of greater than or equal to 6000 IU/sq m three times weekly, was demonstrated to be an effective agent in reinduction of remissions in childhood leukemia. Four hundred thirteen children with acute lymphocytic leukemia were treated with L-asparaginase. Doses i.m. ranged from 300 to 12,000 IU/sq m. None of the patients had received prior asparaginase therapy. 6-Mercaptopurine was given p.o. concurrently. All of the patients had experienced several previous relapses, and their disease was not responsive to 6-mercaptopurine. L-Asparaginase was found to be effective in reinducing remissions at the following rates: 9.5% for 300 IU/sq m; 35.1% for 3,000 IU/sq m; 53.5% for 6,000 IU/sq m; and 62.5% for 12,000 IU/sq m. The drug was given three times weekly for four weeks. Hypersensitivity reactions occurred in 6.5% of patients.

[1]  J. Palmblad,et al.  Hypersensitive reactions and antibody formation during L‐asparaginase treatment of children and adults with acute leukemia , 1976, Cancer.

[2]  J. Burchenal,et al.  Intensive chemotherapy in children with acute lymphoblastic leukemia (L‐2 protocol) , 1974, Cancer.

[3]  V. Land,et al.  Toxicity of L‐asparaginase in children with advanced leukemia , 1972 .

[4]  C. Pratt,et al.  Low-dosage asparaginase treatment of childhood acute lymphocytic leukemia. , 1971, American journal of diseases of children.

[5]  E. Henderson,et al.  L-asparaginase (NSC-109229) plus azaserine (NSC-742) in acute lymphatic leukemia. , 1970, Cancer chemotherapy reports.

[6]  D. Karnofsky,et al.  Toxicity of E. coli L‐asparaginase in man , 1970, Cancer.

[7]  D. Karnofsky,et al.  E. coli L‐asparaginase in the treatment of leukemia and solid tumors in 131 children , 1970, Cancer.

[8]  P. Carbone,et al.  L-asparaginase: therapeutic and toxic effects in patients with neoplastic disease. , 1969, The New England journal of medicine.

[9]  J. Wolff,et al.  Varying prednisone dosage in remission induction of previously untreated childhood leukemia , 1968, Cancer.

[10]  J. H. Kim,et al.  Inhibition of leukemias in man by L-asparaginase. , 1967, Cancer research.

[11]  For April. , 1903 .

[12]  S. George,et al.  Evaluation of dose and schedule of L-asparaginase in multidrug therapy of childhood leukemia. , 1976, Medical and pediatric oncology.

[13]  B. Kim,et al.  Favorable remission induction rate with twice weekly doses of L-asparaginase. , 1973, Cancer research.